Cargando…
Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648362/ https://www.ncbi.nlm.nih.gov/pubmed/34872955 http://dx.doi.org/10.1503/cmaj.210831 |
_version_ | 1784610786411282432 |
---|---|
author | Weinstein, Jordan Girard, Louis-Philippe Lepage, Serge McKelvie, Robert S. Tennankore, Karthik |
author_facet | Weinstein, Jordan Girard, Louis-Philippe Lepage, Serge McKelvie, Robert S. Tennankore, Karthik |
author_sort | Weinstein, Jordan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8648362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | CMA Joule Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86483622021-12-12 Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors Weinstein, Jordan Girard, Louis-Philippe Lepage, Serge McKelvie, Robert S. Tennankore, Karthik CMAJ Review CMA Joule Inc. 2021-12-06 /pmc/articles/PMC8648362/ /pubmed/34872955 http://dx.doi.org/10.1503/cmaj.210831 Text en © 2021 CMA Joule Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Review Weinstein, Jordan Girard, Louis-Philippe Lepage, Serge McKelvie, Robert S. Tennankore, Karthik Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors |
title | Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors |
title_full | Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors |
title_fullStr | Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors |
title_full_unstemmed | Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors |
title_short | Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors |
title_sort | prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648362/ https://www.ncbi.nlm.nih.gov/pubmed/34872955 http://dx.doi.org/10.1503/cmaj.210831 |
work_keys_str_mv | AT weinsteinjordan preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors AT girardlouisphilippe preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors AT lepageserge preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors AT mckelvieroberts preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors AT tennankorekarthik preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors |